About Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co
Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co is a company based in Pudong (China) founded in 1996.. Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co operates in a competitive market with competitors including TScan Therapeutics, GigaGen, Shattuck Labs, Boundless Bio and Bolt Biotherapeutics, among others.
- Headquarter Pudong, China
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$96.17 M (USD)-16.96as on Dec 31, 2024
-
Net Profit
$5.44 M (USD)-63.42as on Dec 31, 2024
-
EBITDA
$10.2 M (USD)-46.45as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co Comparisons
Competitors of Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co
Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TScan Therapeutics, GigaGen, Shattuck Labs, Boundless Bio and Bolt Biotherapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
T cell-based treatments for immunological and oncological disorders are developed.
|
|
| domain | founded_year | HQ Location |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms.
|
|
| domain | founded_year | HQ Location |
An immunotherapy platform for oncology and other diseases is developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer are developed by targeting ecDNA.
|
|
| domain | founded_year | HQ Location |
T-cell therapies for cancer treatment are developed by Bolt Biotherapeutics.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co
Frequently Asked Questions about Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co
When was Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co founded?
Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co was founded in 1996.
Where is Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co located?
Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co is headquartered in Pudong, China. It is registered at Pudong, Shanghai, China.
What is the annual revenue of Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co?
Annual revenue of Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co is $96.17M as on Dec 31, 2024.
What does Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co do?
Photodynamic drugs, genetically engineered therapies, and nanotechnology-based drug delivery systems are developed by Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co., founded in 1996 in Pudong, China. Aminolevulinic acid hydrochloride and hemoporfin serve as photosensitizers in cancer treatments, while Libord (Doxorubicin liposome) is marketed for oncology applications. Operations focus on biopharmaceutical innovation within the cancer therapy sector.
Who are the top competitors of Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co?
Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co's top competitors include Lyell Immunopharma, GigaGen and Shattuck Labs.